GastroPath™

GastroPath™

Over 1,800 microbial species colonize the human intestinal tract and many more enter through food and water sources. Clostridium difficile, Escherichia coli and Salmonella enterica infection often occur due to consumption of contaminated food. In addition, the Vibrio cholerae infection often occurs specifically from consuming raw seafood.

The potential for a Norovirus epidemic exists throughout the worldwide cruise ship industry. Travelers often bring rare parasitic worm infections from other endemic countries. The Norovirous can often spread rapidly through the entire vessel, whether it is at port or in transit. Diarrhea, vomiting and other symptoms such as unspecified fever are often associated with Norovirus infections. Left undiagnosed or untreated, Noravirus can lead to appendicitis or death.

Antibiotic prescriptions for patients suffering from C. diff pathogen with toxin A/B or Vibrio cholerae with toxin CtxA lead to pathogen cell explosion and catastrophic toxin release. NCF Diagnostics & DNA Technologies developed the GastroPath™ test to prevent such emergencies from occurring.

NCF Diagnostics & DNA Technologies designed the GastroPath™ test kit with a comprehensive pathogen list. Our laboratory has tested over 50,000 fecal swab specimens from primary care, gastroenterology, pediatrics and other subspecialty clinics since 2017.

NCF Diagnostics & DNA Technologies now offers our GastroPath™ test kit to physicians for fecal specimen collection in a sterile cotton swab. The specimen is then submitted for Real-Time PCR analysis to identify the pathogen species and its specific quantity.

Download 2021 NCF_GastroPath_Requisition Form